FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a pharmaceutical composition based on 6-amino-9-[(3R)-1-(2-butinoyl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purine-8-one hydrochloride, which has the activity of a selective Btk inhibitor, useful for the prevention and/or treatment of Btk-related diseases. The invention also relates to the use of 6-amino-9-[(3R)-1-(2-butinoyl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purine-8-one hydrochloride.
EFFECT: pharmaceutical composition based on a Btk inhibitor has been obtained that is useful for the treatment of non-Hodgkin's lymphoma, autoimmune disease, and other Btk-related diseases.
6 cl, 4 dwg, 6 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYDROCHLORIDE OF DERIVATIVE PURINONA | 2012 |
|
RU2615999C2 |
| PURINONE DERIVATIVE | 2011 |
|
RU2575340C2 |
| COMBINED THERAPY BASED ON CD20 ANTIBODY AND BTK INHIBITOR | 2014 |
|
RU2727650C2 |
| COMBINATION THERAPY BASED ON ANTI-CD20 ANTIBODY AND BTK INHIBITOR | 2021 |
|
RU2815679C2 |
| PURINONE COMPOUNDS AS KINASE INHIBITORS | 2013 |
|
RU2655388C2 |
| PYRIDINES, PYRIMIDINES AND PYRAZINES AS BRUTON'S TYROSINE KINASE INHIBITORS AND USE THEREOF | 2014 |
|
RU2712220C2 |
| AMINOPIRIDAZINOVE COMPOUNDS AS PROTEINKINASE INHIBITORS | 2014 |
|
RU2674701C2 |
| METHODS FOR TREATMENT OF MALIGNANT TUMOR USING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITY | 2016 |
|
RU2765154C2 |
| SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK, THEIR PREPARATION AND USE IN TREATMENT OF CANCER, INFLAMMATION AND AUTOIMMUNE DISEASES | 2014 |
|
RU2677884C2 |
| PYRIMIDINE DERIVATIVES AS BTK INHIBITORS AND USE THEREOF | 2016 |
|
RU2743040C2 |
